Quinacrine-induced cytolytic hepatitis in sporadic Creutzfeldt-Jakob disease [2]

Annals of Neurology

Volumn 53, Issue 4, 2003, Pages 546-547

  Scoazec, Jean Yves ^a   Krolak Salmon, Pierre ^b   Casez, Olivier ^c   Besson, Gérard ^c   Thobois, Stéphane ^b   Kopp, Nicolas ^b   Perret Liaudet, Armand ^b   Streichenberger, Nathalie ^b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b HÔPITAL NEUROLOGIQUE   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MEPACRINE;

BLOOD TOXICITY; CASE REPORT; CREUTZFELDT JAKOB DISEASE; CYTOLYSIS; DOSE RESPONSE; DRUG MEGADOSE; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETTER; LIVER FUNCTION TEST; LIVER TOXICITY; PRIORITY JOURNAL; RESPIRATORY FAILURE;

EID: 0037379591     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10530     Document Type: Letter

References (5)

1. Doh-Ura K, Iwaki T, Caughey B. Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation. J Virol 2000;74:4894-4897.
2. Korth C, May BC, Cohen FE, et al. Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci USA 2001;98:9836-9841.
3. Danan G. Causality assessment of drug-induced liver injury. Hepatology Working Group. J Hepatol 1988;7:132-136.
4. Zimmerman HJ. Drug-induced liver disease. Clin Liver Dis 2000;4:73-96.
5. Collins SJ, Lewis V, Brazier M, et al. Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model. Ann Neurol 2002;52:503-506.